"The Utility of a Growth Factor: r-HuEPO as a Treatment for Preoperative Autologous Blood Donation in Gynecological Tumor Surgery." International Journal of Oncology, January 1999;14(1):157-160.

Gargano, G.; Polignano, G.; Delena, M.; Brandi, M.; Lorusso, V.; Fanizza, G.

According to the authors' abstract of an article published in International Journal of Oncology, "The use of r-HuEPO and sodium ferrous gluconate has been shown to be a safe and effective treatment which can be used by transfusional centers and surgeons to avoid allogeneic blood transfusions and to schedule short-term selective surgery. In this study the authors submitted 20 patients scheduled to undergo surgery for gynecological tumors to a program of pre-operative autologous blood donation. All the patients received both r-HuEPO and sodium ferrous gluconate in the pre- and post-donation …